ImmuCell
ICCC
21 hedge funds and large institutions have $3.84M invested in ImmuCell in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
5% less funds holding
Funds holding: 22 → 21 (-1)
5.72% less ownership
Funds ownership: 19.78% → 14.06% (-5.7%)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
48% less capital invested
Capital invested by funds: $7.34M → $3.84M (-$3.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$101K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$63.8K |
| 3 |
BlackRock
New York
|
+$54.2K |
| 4 |
Renaissance Technologies
New York
|
+$38.2K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$10.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.46M |
| 2 |
AC
Antara Capital
New York
|
-$541K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$132K |
| 4 |
EFS
Essex Financial Services
Essex,
Connecticut
|
-$111K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$66K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | +$172 | +35 | New |
|
ICCC Hedge Fund Activity: Q1 2020 in Review
21 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2020, worth a combined $3.84M — down 48% from $7.34M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ICCC and 5 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $101K. The largest seller was Wellington Management Group, cutting an estimated $1.46M.
- 21 institutional investors held ImmuCell (ICCC) as of Q1 2020, down from 22 in Q4 2019.
- Funds reported $3.84M of ImmuCell stock for Q1 2020, down 48% quarter-over-quarter.
- 5 funds opened new ImmuCell positions in Q1 2020 and 6 closed out, a net change of -1 holder.
- The largest ImmuCell buyer in Q1 2020 was Geode Capital Management, an estimated $101K added.
- The largest ImmuCell seller in Q1 2020 was Wellington Management Group, an estimated $1.46M sold.
Based on aggregated 13F filings for Q1 2020.